Articles & Publications , Thierry Van Nieuwenhove

Thierry Van Nieuwenhove comments on the future of Pharma Manufacturing

In this article by Manufacturing Chemist, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses the future of pharma manufacturing.

Ahead of the upcoming DCAT, Dr. Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond.

Thierry Van Nieuwenhove, CEO of Quotient Sciences recognizes that sustainability and resilience are critical to the future of pharmaceutical development supply chains.

Continue reading the full article on Manufacturing Chemist.

Latest news from Quotient Sciences

More News

Artificial Intelligence, Dr. Andrew Lewis, Articles & Publications Dr. Andrew Lewis Featured in Pharma Fundamentals: Utilizing Artificial Intelligence in Drug Development By: Dr. Andrew Lewis

News & Announcements, Nottingham, UK, Artificial Intelligence Quotient Sciences Advances AI-Designed Drug Product into Clinical Development

Dr. Andrew Lewis, Artificial Intelligence, Formulation Development Dr. Andrew Lewis Featured In BioPharm International: Why AI Fails in Drug Development and How to Build Tools That Actually Deliver Real Value By: Dr. Andrew Lewis

More News

Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.